HCA

HCA Healthcare
D

HCA

Arincen59/100B
495.02
USD
-12.39
(-2.44%)
Pre Open
Fair value430.99Plus+15%232Price 495.02597
Q4 FY2026 · Earnings report
EPS estimate 8.15Revenue estimate 20.02B
OverviewFinancialsNewsForecastEarningsDividendsCompany

HCA Healthcare net income 1990–2026

HCA Healthcare earned 1.58B USD in Q3 FY2026, the three months to 30 September 2026, down 3.9% on the same quarter a year before. HCA Healthcare's net income over the last twelve months was 6.78B USD, up 6.8% on the twelve months before. In fiscal year 2025 it earned 6.78B USD, up 17.8% on the year before.

Last updated 7 Nov 2026 · Next report 26 Jan 2027

Net income

Net income · +12.3% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20266.78B+6.81%8.61%78.70B
FY202531 Dec 20256.78B+17.78%8.97%75.60B
FY202431 Dec 20245.76B+9.88%8.16%70.60B
FY202331 Dec 20235.24B-7.11%8.07%64.97B
FY202231 Dec 20225.64B-18.88%9.37%60.23B
FY202131 Dec 20216.96B+85.30%11.84%58.75B
FY202031 Dec 20203.75B+7.10%7.28%51.53B
FY201931 Dec 20193.51B-7.45%6.83%51.34B
FY201831 Dec 20183.79B+70.89%8.11%46.68B
FY201731 Dec 20172.22B-23.32%5.08%43.61B
FY201631 Dec 20162.89B+35.74%6.97%41.49B
FY201531 Dec 20152.13B+13.55%5.37%39.68B
FY201431 Dec 20141.88B+20.50%5.08%36.92B
FY201331 Dec 20131.56B-3.05%4.55%34.18B
FY201231 Dec 20121.61B-34.89%4.86%33.01B
FY201131 Dec 20112.47B+104.23%7.58%32.51B
FY201031 Dec 20101.21B+14.52%3.93%30.68B
FY200931 Dec 20091.05B+56.61%3.51%30.05B
FY200831 Dec 2008673.00M-23.00%2.37%28.37B
FY200731 Dec 2007874.00M-15.64%3.25%26.86B
FY200631 Dec 20061.04B-27.25%4.07%25.48B
FY200531 Dec 20051.42B+14.29%5.82%24.46B
FY200431 Dec 20041.25B-6.46%5.30%23.50B
FY200331 Dec 20031.33B+59.90%6.11%21.81B
FY200231 Dec 2002833.00M-5.98%4.22%19.73B
FY200131 Dec 2001886.00M+203.42%4.94%17.95B
FY200031 Dec 2000292.00M-60.54%1.75%16.67B
FY199931 Dec 1999740.00M+57.11%4.44%16.66B
FY199831 Dec 1998471.00M—2.52%18.68B
FY199731 Dec 1997-305.00M-120.27%-1.62%18.82B
FY199631 Dec 19961.51B+56.61%7.56%19.91B
FY199531 Dec 1995961.00M+52.54%5.43%17.70B
FY199431 Dec 1994630.00M+24.26%5.66%11.13B
FY199331 Dec 1993507.00M+1,888.24%4.95%10.25B
FY199231 Dec 199225.50M+67.76%3.35%761.60M
FY199131 Dec 199115.20M+55.10%3.30%461.00M
FY199031 Dec 19909.80M—3.60%272.60M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about HCA Healthcare's profit

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.